Immunic market cap

Author: aprm

August undefined, 2024

WitrynaImmunic market cap history and chart from 2013 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Immunic market cap as of September 23, 2024 is $0.1B . Witryna1 dzień temu · Immunic Inc CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase... April 13, 2024

Immunic’s positive trial data for IMU-838 impresses analysts

Witryna12 kwi 2024 · Companies. Finance. Industry Witryna15 kwi 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol "IMUX" on April 15, 2024. Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic … how to shave without getting ingrown

Immunic Inc. (IMUX) Shares Up Despite Recent Market Volatility

Witryna10 paź 2024 · Immunic anticipates the gross proceeds from the PIPE to be approximately $60.0 million, before deducting any offering related expenses. The financing is expected to close on October 12, 2024 ... Witryna21 paź 2024 · Four months after taking an axe to the pipeline resulting from a Phase II miss, Immunic is back with another miss. ... RBC Capital Markets’ Healthcare Technology Analyst, Sean Dodge, spotlights ... Witryna12 kwi 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol "IMUX" on April 15, 2024. Immunic, Inc. is a ... notre d football schedule

Immunic Therapeutics - Funding, Financials, Valuation & Investors

Immunic (IMUX)Key Financial Indicators - Moomoo

Witryna20 paź 2024 · The EIB and Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the signing of a €24.5 million financing agreement. The venture loan is intended to … Witryna23 lut 2024 · NEW YORK, February 23, 2024 - Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small … notre dam chemistryWitrynaThe global crypto market cap is $1.29T, a 2.93 % increase over the last day. Read More The total crypto market volume over the last 24 hours is $55.57B , which makes a 10.16 % increase. notre d ball schedule 2021 tv

"WitrynaFind the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 61.277M: Beta (5Y Monthly) 1.70: PE ... " - Immunic market cap

Immunic market cap

Immunic’s positive trial data for IMU-838 impresses analysts

Witryna1 dzień temu · Detailed statistics for Immunic, Inc. (IMUX) stock, including valuation metrics, financial numbers, share information and more. ... Immunic has a market … WitrynaIMUX: Get the latest Immunic stock price and detailed information including IMUX news, historical charts and realtime prices. ... Market Cap. 44.40 M Number of Shares. 1.30 Day Low. 1.38 ...

Did you know?

Witryna2 dni temu · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Vitt describes it as "wonderful data" that came as a "positive … Witryna3 sty 2024 · About Immunic, Inc. 11440 WEST BERNARDO COURT SUITE 300, SAN DIEGO, California, 92127, United States +49 89 2500794 60 https:/www.imux.com. …

WitrynaContact Email [email protected]. Phone Number +4989208047700. Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products; its lead development program, … Witryna6 kwi 2024 · Immunic has caught the attention of market analysts with the release of positive data from the maintenance phase of its Phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC).. The company on Wednesday said data from the maintenance phase of …

Witryna10 kwi 2024 · A high-level overview of Immunic, Inc. (IMUX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WitrynaCompany information for Immunic Inc USD0.0001 share priceincluding general stock details, key personnel and important dates for your diary. ... Market cap: $78.15 million Shares in issue: 44.40 ...

Witryna14 kwi 2024 · Immunic Inc (IMUX) is down -5.26%% today. IMUX has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on IMUX!See Full IMUX ReportIMUX stock closed at $1.52 ...

Witryna10 godz. temu · Mark Mobius, seasoned investor and founder of Mobius Capital, believes that the concerns around the Indian ports-to-energy conglomerate Adani … notre dame 175 wineWitryna10 kwi 2024 · At the end of the latest market close, Immunic Inc. (IMUX) was valued at $1.55. In that particular session, Stock kicked-off at the price of $1.54 while reaching the peak value of $1.55 and lowest value recorded on the day was $1.36. The stock current value is $1.39.Recently in News on April 5, 2024 how to shave without getting ingrownsWitryna17 lis 2024 · November 17, 2024. NEW YORK, Nov. 17, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the formation of a Scientific-Medical … notre dam stained glass radianceWitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net notre dame 1963 football rosterWitryna23 godz. temu · View Immunic, Inc IMUX investment & stock information. Get the latest Immunic, Inc IMUX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... Market Cap 61.28 M Dividend 0. ... how to shave without hurtingWitrynaImmunic (IMUX) - Net assets Net assets on the balance sheet as of December 2024 : $0.11 B. According to Immunic's latest financial reports the company has $0.11 B in … how to shave without getting ingrown hairsWitryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. News provided by. Immunic, Inc. Nov 03, 2024, 06:30 ET. – $72.8 Million in Cash and Cash Equivalents as ... how to shave without hurting yourself